Prenatal deletion detection in a sporadic case of Duchenne muscular dystrophy without genotype information from the affected individual
- 69 Downloads
We describe the application of deletion screening by amplification of deletion-prone exons via polymerase chain reaction (PCR) in a family with a sporadic case of Duchenne muscular dystrophy (DMD). No DNA was available from the affected patient who died 12 years beforehand at the age of 18 years. Material obtained prenatally from two male fetuses exhibited an identical deletion. These findings effectivly transformed a sporadic case into a familial case and a numerical carrier risk was substituted by obligate carrier status. Additionally an indirect genotype analysis was replaced by the possibility of direct DNA analysis. Genetic counselling, formerly based upon incomplete data, can now be aided by precise risk assessment.
Key wordsDuchenne muscular dystrophy Deletion screening Prenatal diagnosis Polymerase chain reaction
Duchenne muscular dystrophy
polymerase chain reaction
restriction fragment length polymorphism
Unable to display preview. Download preview PDF.
- 1.Bakker E, Hofker MH, Goor N, Mandel JL, Wrogemann K, Davies KE, Kunkel LM, Willard HF, Fenton WA, Sandkuyl L, Majoor-Krakauer D, Van Essen AJ, Jahoda MGH, Sachs E, Van Ommen GJB, Pearson PL (1985) Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet I:655–658Google Scholar
- 5.Darras BT, Blattner P, Harper JF, Spiro AJ, Alter S, Francke U (1988) Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BgIII exon-containing fragment maps, meiotic and mitotic origin of the mutations. Am J Hum Genet 43:620–629PubMedGoogle Scholar
- 8.Haldane JBS (1935) The rate of spontaneous mutations of a human gene. J Genet 31:317–326Google Scholar
- 15.Nicholson GA, Gardner-Medwin D, Pennington RJT, Walton JN (1979) Carrier detection in Duchenne muscular dystrophy: assessment of the effect of age on detection-rate with serum-creatine-kinase-activity. Lancet I:692–694Google Scholar